Q32 Bio (NASDAQ:QTTB) Research Coverage Started at Piper San

Q32 Bio (NASDAQ:QTTB) Research Coverage Started at Piper Sandler

Piper Sandler started coverage on shares of Q32 Bio (NASDAQ:QTTB – Free Report) in a report issued on Tuesday, Marketbeat.com reports. The brokerage issued an overweight rating and a $45.00 price target on the stock. Q32 Bio Stock Down 2.7 % QTTB stock opened at $20.71 on Tuesday. The company has a market cap of […]

Related Keywords

Piper Sandler , Homology Medicines Inc , Free Report , Stock Down , Get Free Report , Medicines Inc , Q32 Bio , Nasdaq Qttb , Qttb , Medical , Initiated Coverage ,

© 2025 Vimarsana